Literature DB >> 5266079

Xg locus: failure to detect inactivation in females with chronic myelocytic leukaemia.

P J Fialkow, R Lisker, E R Giblett, C Zavala.   

Abstract

Entities:  

Mesh：

Year:  1970        PMID： 5266079     DOI： 10.1038/226367a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  The molecular genetic background leading to the formation of the human erythroid-specific Xga/CD99 blood groups.

Authors:  Chih-Chun Yeh; Ching-Jin Chang; Yuh-Ching Twu; Chen-Chung Chu; Bi-Shan Liu; Ji-Ting Huang; Shu-Ting Hung; Yung-Syu Chan; Yi-Jui Tsai; Sheng-Wei Lin; Marie Lin; Lung-Chih Yu
Journal:  Blood Adv       Date:  2018-08-14

2.  Developmental, tissue-specific, and sex differences in activity among three enzymes from human erythrocytes and cultured fibroblasts.

Authors:  M W Steele; K E Owens
Journal:  Biochem Genet       Date:  1973-06       Impact factor: 1.890

Review 3.  [Philadelphia chromosome].

Authors:  D K Hossfeld; A A Sandberg
Journal:  Klin Wochenschr       Date:  1970-12-15

4.  Xg groups and sex abnormalities in people of northern European ancestry.

Authors:  R Sanger; P Tippett; J Gavin
Journal:  J Med Genet       Date:  1971-12       Impact factor: 6.318

5.  The X-linked blood group system Xg. Tests on unrelated people and families of northern European ancestry.

Authors:  R Sanger; P Tippett; J Gavin
Journal:  J Med Genet       Date:  1971-12       Impact factor: 6.318

6.  X-chromosome inactivation and the Xg locus.

Authors:  P J Fialkow
Journal:  Am J Hum Genet       Date:  1970-07       Impact factor: 11.025

7.  Linkage of genes for chronic granulomatous disease and Xg.

Authors:  G Wolff; C R Müller; A Jobke
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

8.  A comparative study on steroid sulfatase and arylsulfatase C in fibroblast clones from 45,X/47,XXX and 69,XXY.

Authors:  W Vogel; M Grompe; R Storz; S Pentz
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.